Revenue

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Jun '25 Jun 30, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Biopharmaceutical Medicines Revenue	6.66T	6.03T	6.07T
Biopharmaceutical Medicines Revenue Growth	10.45%	-0.61%	224.01%
Chemical Medicines Revenue	517.00B	556.71B	531.39B
Chemical Medicines Revenue Growth	-7.13%	4.76%	6.11%
Other Segments Revenue	7.24B	6.74B	5.82B
Other Segments Revenue Growth	7.46%	15.67%	13.25%
Adjustments to Revenue	-3,438.85B	-2,434.23B	-3,050.04B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Jun '25 Jun 30, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Domestic Revenue	1.48T	1.26T	1.55T
Domestic Revenue Growth	17.32%	-18.84%	-26.41%
Asia Revenue	211.23B	309.00B	192.46B
Asia Revenue Growth	-31.64%	60.55%	204.16%
Europe Revenue	1.65T	2.01T	1.50T
Europe Revenue Growth	-17.68%	33.91%	-
North America Revenue	279.01B	419.96B	168.09B
North America Revenue Growth	-33.56%	149.85%	-
Central and South America Revenue	123.60B	161.78B	140.96B
Central and South America Revenue Growth	-23.60%	14.77%	-

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Jun '25 Jun 30, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Biopharmaceutical Medicines Operating Income	1.47T	1.22T	1.20T
Biopharmaceutical Medicines Operating Income Growth	21.29%	1.33%	87.84%
Chemical Medicines Operating Income	14.11B	23.73B	9.18B
Chemical Medicines Operating Income Growth	-40.53%	158.37%	-67.04%
Other Segments Operating Income	1.37B	86.19M	505.60M
Other Segments Operating Income Growth	1488.31%	-82.95%	11.43%
Adjustments to Operating Income	-693.18B	-70.39B	-716.79B

Updated Jun 30, 2025. Data Source: Fiscal.ai.